A phase 3 study comparing switching from tenofovir disoproxil fumarate to tenofovir alafenamide with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results

被引：0

作者：

Lampertico, Pietro ^{[1
]}

Buti, Maria ^{[2
]}

Fung, Scott ^{[3
]}

Ahn, Sang Hoon ^{[4
]}

Chuang, Wan-Long ^{[5
]}

Ramji, Alnoor ^{[6
]}

Tak, Won Young ^{[7
]}

Chen, Chiyi ^{[8
]}

Tam, Edward ^{[9
]}

Bae, Ho ^{[10
]}

Ma, Xiaoli ^{[11
]}

Flaherty, John F. ^{[12
]}

Gaggar, Anuj ^{[12
]}

Lau, Audrey ^{[12
]}

Feierbach, Becket ^{[12
]}

Wu, George ^{[12
]}

Suri, Vithika ^{[12
]}

Subramanian, Mani ^{[12
]}

Trinh, Huy N. ^{[13
]}

Yoon, Seung Kew ^{[14
]}

Agarwal, Kosh ^{[15
]}

Lim, Young-Suk ^{[16
]}

Chan, Henry ^{[17
]}

机构：

[1] Univ Milan, Div Gastroenterol & Hepatol, Milan, Italy

[2] Univ Hosp Vall dHebron, Barcelona, Spain

[3] Univ Hlth Network, Toronto, ON, Canada

[4] Yonsei Univ, Seoul, South Korea

[5] Kaohsiung Med Univ, Kaohsiung, Taiwan

[6] Gastrointestinal Res Inst, Vancouver, BC, Canada

[7] Kyungpook Natl Univ, Coll Med, Daegu, South Korea

[8] Chia Yi Christian Hosp, Chiayi, Taiwan

[9] LAIR Ctr, Vancouver, BC, Canada

[10] St Vincents Med Ctr, Los Angeles, CA USA

[11] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA

[12] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[13] San Jose Gastroenterol, San Jose, CA USA

[14] Catholic Univ Korea, Seoul, South Korea

[15] Kings Coll Hosp London, London, England

[16] Univ Ulsan, Coll Med, Seoul, South Korea

[17] Prince Wales Hosp, Hong Kong, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

10.1016/S0618-8278(19)30928-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

FRI-183

引用

页码：E470 / E471

页数：2

共 50 条

[21] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Chan, Henry Lik Yuen
Lim, Young-Suk
Seto, Wai Kay
Ning, Qin
Agarwal, Kosh
Janssen, Harry L. A.
Pan, Calvin O.
Chuang, Wan Long
Izumi, Namiki
Fung, Scott
Shalimar
Brunetto, Maurizia
Flaherty, John
Mo, Shuyuan
Cheng, Cong
Lin, Lanjia
Gaggar, Anuj
Subramanian, Mani
Marcellin, Patrick
Gane, Edward
Hou, Jinlin
Buti, Maria
GUT, 2020, 69 : A75 - A76
[22] From Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Perspectives in Pediatric Patients with Chronic Hepatitis B
Rodrigo, Minna
Hartley, Christopher
Wasuwanich, Paul
Van, Trung
Karnsakul, Wikrom
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (12) : 1099 - 1106
[23] SAFETY AND EFFICACY AT 48 WEEKS AFTER SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) TO TENOFOVIR ALAFENAMIDE (TAF) IN CHRONIC HBV PATIENTS WITH RISK FACTORS FOR TDF USE
Buti, Maria
Lampertico, Pietro
Lim, Young-Suk
Agarwal, Kosh
Fung, Scott K.
Tsang, Owen
Elkhashab, Magdy
Kao, Jia-Horng
Luis Calleja, Jose
Khalili, Mandana
Ravendhran, Natarajan
Tan, Susanna
Flaherty, John F.
Gaggar, Anuj
Lau, Audrey H.
Wu, George
Hann, Hie-Won L.
Pan, Calvin
Kim, Hyung Joon
Kennedy, Patrick T. F.
Chan, Henry Lik Yuen
HEPATOLOGY, 2019, 70 : 301A - 301A
[24] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
Lim, Young-Suk
Chan, Henry Lik Yuen
Seto, Wai-Kay
Ning, Qing
Agarwal, Kosh
Janssen, Harry L. A.
Pan, Calvin Q.
Chuang, Wan Long
Izumi, Namiki
Fung, Scott K.
Shalimar
Brunetto, Maurizia R.
Flaherty, John F.
Mo, Shuyuan
Cheng, Cong
Lin, Lanjia
Gaggar, Anuj
Subramanian, Mani
Marcellin, Patrick
Gane, Edward J.
Hou, Jinlin
Buti, Maria
HEPATOLOGY, 2019, 70 : 126A - 127A
[25] EFFECTIVENESS AND SAFETY OF SWITCHING TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR TO TENOFOVIR ALAFENAMIDE FUMARATE ( TAF) IN VIROLOGICALLY SUPPRESSED CHRONIC HEPATITIS B VIRUSINFECTED PATIENTS WITH ONEMINUTE OSTEOPOROSIS RISK TEST
Li, Hui
Li, Chunmei
Wei, Jia
Liu, Yunhua
Gong, Ming
Zhang, Ruyi
Geng, Jiawei
Wang, Hongyan
Yu, Zhijian
Wang, Zi
Liu, Xiang
HEPATOLOGY, 2023, 78 : S513 - S513
[26] COMPARATIVE SAFETY OF TENOFOVIR DISOPROXIL FUMARATE AND TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS
Yu, N. Y.
Chang, K. C.
VALUE IN HEALTH, 2020, 23 : S532 - S532
[27] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study
Lampertico, Pietro
Buti, Maria
Fung, Scott
Ahn, Sang Hoon
Chuang, Wan-Long
Tak, Won Young
Ramji, Alnoor
Chen, Chi-Yi
Tam, Edward
Bae, Ho
Ma, Xiaoli
Flaherty, John F.
Gaggar, Anuj
Lau, Audrey
Liu, Yang
Wu, George
Suri, Vithika
Tan, Susanna K.
Subramanian, G. Mani
Trinh, Huy
Yoon, Seung-Kew
Agarwal, Kosh
Lim, Young-Suk
Chan, Henry L. Y.
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (05): : 441 - 453
[28] Switching from a tenofovir disoproxil fumarate (TDF)-based regimen to a tenofovir alafenamide (TAF)-based regimen: data in virologically suppressed adults through 48 weeks of treatment
Mills, Tony
Andrade, Jamie
Diperri, Giovanni
Van Lunzen, Jan
Koenig, Ellen
Elion, Richard
Cavassini, Matthias
Madruga, Jose Valdez
Brunetta, Jason
Shamblaw, David
Dejesus, Edwin
Cohen, Calvin
Plummer, Andrew
Liu, Yapei
McCallister, Scott
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2015, 18
[29] Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naive patients with chronic hepatitis B
Lim, Jihye
Choi, Won-Mook
Shim, Ju Hyun
Lee, Danbi
Kim, Kang Mo
Lim, Young-Suk
Lee, Han Chu
Choi, Jonggi
JOURNAL OF HEPATOLOGY, 2022, 77 : S842 - S842
[30] SWITCHING FROM TENOFOVIR DISOPROXIL FUMARATE (TDF) AND/OR OTHER ORAL ANTIVIRALS (OAVS) TO TENOFOVIR ALAFENAMIDE (TAF) IN VIRALLY SUPPRESSED CHRONIC HEPATITIS B (CHB) PATIENTS WITH HEPATIC IMPAIRMENT: FINAL 2-YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 2
Lim, Young-Suk
Lin, Chun-Yen
Heo, Jeong
Bae, Ho
Chuang, Wan-Long
Yin, Tak
Tsang, Owen
Fournier, Claire
Hui, Aric Josun
Trinh, Huy
Chan, Carol Yee Kwan
Tan, Susanna K.
Zhao, Yang
Flaherty, John F.
Suri, Vithika
Gaggar, Anuj
Brainard, Dianna M.
Ryder, Stephen
La Janssen, Harry
GUT, 2021, 70 : A77 - A77

← 1 2 3 4 5 →